Document:

EX-10.3

 Exhibit 10.3 
  

 
 May 23, 2011 
 Kevin
McArdle 
 19 Radmore Street 
 Worcester, MA 01602 

 

	Re:	Offer of Employment as Chief Financial Officer 

 Dear Kevin: 

I am pleased to offer you employment in the position of Chief Financial Officer of Histogenics, Inc. (“the Company”), commencing on
May 15, 2011. The purpose of this letter is to describe the general terms and conditions of your employment with the Company. 
 Duties and
Responsibilities 
 Your duties and responsibilities shall include those normally associated with the position of Chief Financial Officer
and such other duties and responsibilities as reasonably may be assigned to you from time to time by the President, Chief Executive Officer of the Company. Your employment with the Company will be on a full-time basis. You will be expected to devote
full time and effort to the business of the Company. 
 Salary Compensation 

Your annual salary will be $190,000 (“Base Salary”), less applicable tax withholdings, payable in installments in accordance with the
Company’s regular payroll practices. Your compensation and benefits will terminate upon termination of your employment. 
 Bonus Compensation

 You will be eligible for an annual bonus (“Bonus”) as determined by the Board of Directors, based upon the recommendation of
the President & Chief Executive Officer, to be determined and paid within 90 days from the end of the Company’s fiscal year, in an amount up to 20% of your Base Salary. The Bonus, if any, shall be determined by the Board of
Directors in its sole discretion based on your performance and the Company’s performance during the course of the preceding year and your success at achieving objectives and goals set for you individually and the Company’s success at
achieving its objectives and goals. Such goals and objectives will be determined by the President and Chief Executive Officer. 
 Equity/Stock Options

 Subject to your acceptance of this offer of employment, upon approval of the Board of Directors which is anticipated to occur at the
time the Company closes its Series B financing, you will be issued stock options to purchase 179,097 shares of the common stock of the Company (the “Options). The exercise price of the Options will be equal to the fair market value

 
of the Company’s Common stock on the date of grant, which will be determined upon completion of the Series B Preferred Stock financing. Assuming your continued employment by the
Company, the Options will vest over four years, with 25% vesting on a ‘cliff’ basis one year after the date of grant and the remainder vesting in equal quarterly installments each year thereafter. 

Vacation 
 You shall be eligible to take
up to 15 days of paid vacation time per year, calculated from the anniversary date of the commencement of your employment and consistent with the Company’s vacation policy. Such vacation time is accrued during employment on a monthly
basis. Consistent with the Company’s vacation policy, you may carryover 50% of accrued but unused vacation time into subsequent years, but no more than 20 days may be carried over into any year. 

Expenses 
 The Company will reimburse you
for all actual, necessary and reasonable expenses you incur in the course of the Company’s business, subject to the Company’s expense policy. 

Benefits 
 You will be entitled to receive
the fringe benefits generally available to the Company’s employees. The Company, of course, may amend, terminate or enhance the benefits provided to you and our other employees from time to time as it deems appropriate. 

Internal Policies 
 During your employment
with the Company, you will be required to follow all of the Company’s internal policies and to conduct your business activities at all times in accordance with the highest legal, ethical and professional standards. 

Employment At Will 
 Your employment with
the Company shall be at-will. As such, your employment is for no definite period of time, and you or the Company may terminate your employment relationship with or without notice at any time and for any or no reason or cause. This offer of
employment should not be construed as a guarantee of employment for any specific duration, and the terms of your employment may be changed by the Company at any time. 

Severance 
 In the event that your
employment is terminated by either the Company or you for any reason, the Company shall pay to you all unpaid Base Salary and unused vacation earned through the date of termination of employment. You will also be reimbursed for any reasonable
business expenses that you incurred prior to the termination of employment, as long as you properly account for the expenses and submit appropriate documentation to the Company pursuant to the “Expenses” section above. You will also be
entitled to, and the Company shall pay you, any Bonus previously awarded to you by the Board of Directors but unpaid for any period of employment prior to the termination of employment. 

 In the event you voluntarily resign your employment or the Company terminates your employment for
“Cause” (as defined herein), you shall not be entitled to any additional compensation, bonuses or severance (except for those payments and benefits set forth in the immediately preceding paragraph. If the Company terminates your employment
without Cause, you shall be entitled to receive the following payments and benefits (the “Severance Benefits”): (i) continuation of the payment of your Base Salary for a period of twelve weeks in the first year of employment and
twenty-four weeks in every year after the first year (the “Severance Period”), paid in monthly installments in accordance with the Company’s payroll practices and subject to applicable tax withholding; (ii) acceleration of
vesting of your stock options as if your employment continued for a period of 8 weeks following such termination of; and (iii) reimbursement of the applicable premium for COBRA continuation coverage for the Severance Period. Notwithstanding any
provision of this offer letter, the Severance Benefits are conditioned on your execution and delivery to the Company, and non-revocation, of a release of all claims against the Company in a form acceptable to the Company that becomes effective
within 45 days following termination of your employment. The Severance Benefits will commence on the date on which the release becomes effective.] 

For the purposes of this paragraph, “Cause” shall mean: (i) your indictment or conviction of any felony or of any crime
involving dishonesty or moral turpitude, (ii) your breach of this offer letter or your Proprietary Information, Inventions and. Non-Solicitation Agreement, (iii) your refusal to abide by or comply with the legal directives of the Board of
Directors or the President and Chief Executive Officer, (iv) your dishonesty, fraud, or misconduct with respect to the business or affairs of the Company, or any other conduct which may negatively impact the Company’s reputation,
(v) your negligence or failure to perform your duties as determined in the sole discretion of the President and Chief Executive Officer, or (vi) your failure to comply in any material respect with any of the Company’s policies,
including those regarding: (a) business ethics, (b) drug or alcohol use, (c) equal employment opportunity, or (d) sexual or other unlawful harassment. 

No Conflicting Obligation/Conflicts of Interest 

You hereby represent and warrant to the Company that you are not presently under and will not become subject to any obligation to any person or
entity which is inconsistent or in conflict with your employment with the Company or which would prevent, limit or impair in any way your performance of your duties to the Company as described in this letter. Specifically you represent and warrant
that you have not brought with you any confidential or proprietary information of any former employer, and you are not subject to any agreement or obligation with a former employer that would prohibit, impair or interfere with your employment by the
Company. 
 Proprietary Information, Inventions and Non-Solicitation Agreement 

As a condition to your employment by the Company, you are required to enter into the Company’s Proprietary Information, Inventions and
Non-Solicitation Agreement (the “NDA”) 

 
(attached as Exhibit A). Among other things, the NDA provides that the Company owns your work product and all developments made by you related to the Company’s business;
that you shall hold all non-public information regarding the Company confidential; that you will use such confidential information solely in furtherance of the Company’s purposes; that for a period following your employment you will not
solicit, hire, divert or take away any employee, contractor, customer or supplier of the Company. 
 Conditions of Employment 

This offer is contingent upon your providing satisfactory documentation to the Company concerning your employment eligibility as required under
the Immigration Reform and Control Act of 1986. This documentation must be received and accepted by the Company within three (3) business days of your date of hire. 

Governing Law 
 This letter shall be
governed, construed and enforced in accordance with the laws of Massachusetts, without regard to principles of choice or conflicts of law. 
 Arbitration

 The parties hereto agree to arbitrate before a single neutral arbitrator, in accordance with the rules of the American Arbitration
Association in Boston, Massachusetts, any disputes or claims that concern your employment, the termination of your employment, your recruitment to employment, or any term or condition of your employment or this offer letter. The Company and employee
shall equally split the costs of the arbitration filing and hearing fees and the cost of the arbitrator, and any other expense or cost that is unique to arbitration or that you would not be required to bear if you were free to bring the dispute or
claim in court. Each party shall bear its own attorney fees, unless otherwise determined by the arbitrator. Nothing in this offer letter shall be interpreted as restricting or prohibiting you from filing a charge or complaint with an administrative
agency charged with investigating and/or prosecuting such charges or complaints under any applicable law or regulation. The arbitration shall take place in Boston, Massachusetts. The arbitrator shall issue a written award that sets forth the
essential findings and conclusions on which the award is based. Judgment on the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. The award shall be subject to correction, confirmation, or vacation, as
provided by any applicable Massachusetts statutory or case law setting forth the standard of judicial review of arbitration awards. Notwithstanding the foregoing, the parties may apply to any court of competent jurisdiction for preliminary or
interim equitable relief, or to compel arbitration in accordance with this section, without breach of this arbitration provision. You and the Company understand and agree that the arbitration of disputes or claims that relate to this offer letter
shall be instead of a hearing or trial before a court. You and the Company each understand that, except with respect to the enforcement of the NDA by the Company, the parties are expressly waiving any and all rights to a hearing or trial before a
court, regarding any disputes and claims which they now have or which they may in the future have that relate to this offer letter. The only disputes or claims to which the obligations to arbitrate contained in this section shall not apply are to
any dispute or claim for workers’ compensation benefits or unemployment insurance benefits, and the enforcement of the NDA by the Company. 

 Entire Understanding 

This offer letter contains our entire understanding regarding the terms and conditions of your employment and supersedes any prior statements
regarding your employment made to you at any time by any representative of the Company. No representative of the Company, except the President and Chief Executive Officer, has the authority to enter into any agreement contrary to the foregoing. If
the foregoing offer is acceptable to you, please acknowledge your acceptance by signing below and returning one copy of this letter to me no later than May 25, 2011. If we do not hear from you by then, this offer will become null and void. 

Very truly yours, 

 
			
	HISTOGENICS CORPORATION
		
	By:	 	 /s/ Patrick O’Donnell

	
	Patrick O’Donnell,
	
	President and Chief Executive Officer

  

			
	ACCEPTED:
	
	 /s/ Kevin McArdle

	Kevin McArdle
		
	Date:	 	 5-24-11

 

 
 Exhibit A 

CONFIDENTIAL INFORMATION AND 

INTELLECTUAL PROPERTY ASSIGNMENT AGREEMENT 

This Confidential Information and Intellectual Property Assignment Agreement (hereafter referred to as “Agreement”) dated as of
                                 by and between HISTOGENICS CORPORATION
(hereinafter referred to as the “Company”), a Delaware Corporation having a place of business at 830 Winter Street, Waltham, MA 02451, and
                             (hereinafter referred to as the “Employee”), a United States
citizen/legal resident having a residence at
                                         
   . 
 The Company has requested that the Employee execute this Agreement, and the Employee has agreed to execute this
Agreement as part of the terms of Employee being hired, or continued employment of Employee, by the Company; 
 The Company possesses
certain Confidential Information, as defined below in Section 1.5 of this Agreement, that is confidential and proprietary to the Company; 

The Employee may receive or come into possession of Confidential Information from time to time to carry out the Employee’s duties under
the direction of the Company; 
 In furtherance of the foregoing, and in consideration of employment of Employee by the Company, the Company
and the Employee agree as follows: 
 1. DEFINITIONS 

For the purposes of this Agreement, the following terms shall have the following meanings: 

1.1 “Company” means HISTOGENICS CORPORATION, its present or future subsidiaries, affiliates and any entity owned or controlled by or
under common control, including any businesses that may be acquired or established after the execution of this Agreement and employment with the Company, and any successor-in-interest thereto or assignee thereof. 

1.2 “Business of the Company” includes any services or products (including both generic and specific products) used, made, sold,
offered for sale, developed, commenced or planned to be sold by the Company at any time during the Employee’s employment or used, made, sold, offered for sale, developed, commenced or planned to be sold by the Company using Confidential
Information, Intellectual Property or Work Product after termination of the Employee’s employment either by the Employee or the Company. 

 1.3 “Person” and “Persons” mean all individuals, partnerships,
corporations, limited liability companies, firms, businesses, organizations and other entities. 
 1.4 “Field of Research” means the
development of procedures and products related to ex corpus, in situ, in vitro or in vivo growth of cells or tissue for use in a mammalian body such as the human body, including, by way of example and without limitation,
methods of cartilage, ligament and tendon culture, autologous cultured cell technology, the biology of chondrocyte implantation, the applicability of such technology in the treatment of new indications and disease states, the development and
identification of new indications and usages for the Company’s products and procedures, and any and all other procedures and products associated or used with ex corpus, in situ, in vitro or in vivo growth of cells or
tissue for use in a mammalian body. 
 1.5 “Confidential Information” means: 

(a) All information, ideas, trade secrets and all other confidential and proprietary information of the Company, including without limitation
any and all information relating in any manner whatsoever to the Field of Research or the Business of the Company, financial information of the Company, the terms and formats of the Company’s contracts and agreements, information pertaining to
the Company’s methods of operation, processes, strategies and techniques, customer lists, customer information, and information relating to employees of the Company, including but not limited to employees’ identities, home and business
telephone and pager numbers, and addresses; 
 (b) Provided that the information: (i) becomes known to Employee as a consequence of
Employee’s employment with the Company, or was wrongfully obtained by Employee, regardless of whether the information became known to Employee during or after working hours, or whether the information came into the Company’s possession
through the efforts of Employee or others; and (ii) is not readily available to the public; and 
 (c) The definition of
“Confidential Information” is intended to have the broadest meaning as permitted by law and extends beyond the definition of “trade secrets” as set forth in the Uniform Trade Secrets Act. 

1.6 “Employee” means the individual signing this Agreement who is either currently employed by the Company or becoming an employee of
the Company concurrently with the execution of this Agreement. 
 1.7 “Intellectual Property” means any and all ideas, Inventions,
know how, improvements, discoveries, techniques, processes, original works of authorship, trade secrets and other subject matter developed or made by the Employee (solely or jointly with others) that may be protected, at least in part, by one or
more of a patent, trademark, copyright, trade secret, trade dress or other legal protection in the United States or in any foreign country. 

  
 2 

 1.8 “Inventions” means any and all discoveries, concepts, ideas, whether patentable or
not patentable, including but not limited to processes, methods, formulae, software, techniques, algorithms, cells, tissues, organs, cell cultures, cell parts, organisms, natural or non-naturally occurring genetic materials such as DNA constructs,
products, such as proteins, antibodies and the like, that are derived from or produced using natural or non-naturally occurring genetic materials, as well as improvements thereof or know-how related thereto, concerning any present or prospective
activities of the Company with which the Employee becomes acquainted or gains knowledge of as a result of the Employee’s employment by the Company. 

1.9 “Competing Organization” means any Person engaged in or about to become engaged in research on, development of, production,
marketing, selling of, or offering for sale a Competing Product. 
 1.10 “Competing Product” means any product, process, good
or service of any Person other than the Company, in existence or under development, which competes, directly or indirectly, with a product, process, good or service on or with which the Employee has worked for the Company or about which the Employee
has Confidential Information. 
 1.11 “Work Product” means designs, drawings, software, photographs, plans, records,
improvements, ideas and other subject matter relating thereto that is not considered by the Company to be Intellectual Property. 
 2. EMPLOYEE’S
REPRESENTATIONS AND AGREEMENTS 
 2.1 Confidential Information and Goodwill: Solely as a result of employment with the Company,
Employee will be given access to, become familiar with, and will acquire knowledge of the Company, its employees, operations, methods, sources of supply, financial information, the Field of Research, the Business of the Company and other
Confidential Information of the Company. The Confidential Information has been and will continue to be developed through the Company’s investment of substantial time, effort and money. Employee recognizes that disclosure or use of Confidential
Information for any purpose to any third party or Competing Organization would be greatly prejudicial and detrimental to the Company and would cause the Company to suffer immediate and irreparable injury. Employee further recognizes that Employee is
in a position to unfairly convert or otherwise use the Company’s business and goodwill for use by Employee and a Competing Organization to produce, make, have made, sell, offer for sale, or import a Competing Product, and that such conversion
or use would be greatly prejudicial to the Company, and would cause the Company to suffer immediate and irreparable injury. 
 2.2 Ownership of
Employee Work Product: The Company and Employee agree: 
 (a) that the Company shall own in its entirety and have the entire right
to use, made, have made, sell, offer for sale or import without the payment to the Employee of any royalty or amount or the provision of any consideration to Employee, other than 

  
 3 

 
continued employment of the Employee by the Company, all Work Product and all results of the performance by Employee of Employee’s duties and responsibilities as an employee of the Company.
Employee specifically agrees that any Work Product made or conceived by Employee during the period of employment of Employee by the Company shall be delivered to and become the property of the Company; and 

(b) that Employee is obligated to assign and will assign all right, title and interest in and to the Work Product to the Company, without the
payment of any royalty or amount or the provision of any consideration to the Employee other than continued employment by the Company. 
 2.3 Employee
Intellectual Property: Employee agrees that with respect to Intellectual Property made or conceived by the Employee, whether or not during the hour of Employee’s engagement or with the use of assistance of any Company facility,
material, or personnel, either solely or jointly with others during Employee’s employment with the Company or within one year after termination of such employment, without payment, royalty or any other consideration to the Employee other than
Employee’s wages or salary, therefore: 
 (a) The Employee shall inform the Company promptly and fully of all such Intellectual
Property by written reports, setting forth in detail the procedures, steps, materials and the like employed and the results achieved. The Employee shall submit an invention disclosure report promptly after completion of any studies or research
projects undertaken on the Company’s behalf, or funded at least in part by the Company, whether or not in the Employee’s opinion or view a given project has resulted in any Invention; 

(b) The Employee hereby transfers, assigns and agrees to assign to the Company, without any royalty, payment or consideration other than
Employee’s wages or salary which shall be considered full and adequate consideration, his or her entire right, title and interest in and to all Intellectual Property and to applications for United States and foreign patent applications and
patents granted thereon and to any trademarks, trade dress or copyrightable material related thereto; 
 (c) The Employee agrees for himself
or herself and his or her heirs, representatives, successors in interest, and assigns, upon request of the Company, at all times to perform such acts, such as providing testimony in support of the Employee’s inventorship and to execute and
deliver promptly to the Company such papers, instruments and documents, without expense to him or her, as from time to time may be necessary or useful in the Company’s opinion to apply for, secure, maintain, enforce, reissue, extend or defend
the Company’s worldwide rights in any Intellectual Property so as to secure to the Company the full benefits of the Intellectual Property and otherwise to carry into full force and effect the text and the assignment described above; 

(d) The Employee warrants and represents to the Company that he or she is not subject to any agreement, government contract, government grant
or university policy inconsistent with this Agreement. The Employee agrees not to conduct any research or other work subject to this Agreement other than at the Company’s facilities and further agrees not to use any such research facilities,
materials or personnel of any university or other Person not rented, leased or otherwise hired by the Company in connection with such work; and 

  
 4 

 (e) The Employee acknowledges that any copyrightable work created by Employee during the period
of Employee’s employment relationship with the Company shall be considered a work made for hire, and rights therein shall be the exclusive property of the Company as author and owner of the copyright in and to such work. 

2.4 Shop Rights: Notwithstanding any provision herein that may create greater rights, Employee acknowledges that the Company shall have the
royalty-free right to use in its business, and to make, have made, use, sell, offer for sale or import products, processes and services derived from or related to any Intellectual Property or Work Product that are made or conceived by the Employee
during his or her employment by the Company or with the use or assistance of the Company’s facilities or funded, at least in part, with Company funds. 

3. NON-DISCLOSURE OF CONFIDENTIAL INFORMATION: At no time, either during or after the termination of employment, shall Employee directly or
indirectly obtain, disclose, reveal or use for Employee or any Person or Competing Organization, or aid others in obtaining, disclosing, revealing or using any Confidential Information of the Company, other than as may be required in the performance
of duties for and as authorized by the Company. All Confidential Information is and shall remain the sole property of the Company. 
 4. NONDISCLOSURE
OF OTHER INFORMATION: The Company and Employee acknowledge and agree that: 
 (a) Employee may be aware of certain other
confidential information of one or more third parties (the “Third Party Confidential Information”). 
 (b) The Company and
Employee further acknowledge and agree that the Company has not requested that Employee disclose to the Company any Third Party Confidential Information and, in fact, the Company requires that Employee refrain at all times during the period of the
employment relationship between the Company and Employee from using, disclosing or revealing to the Company any Third Party Confidential Information. 

(c) Employee agrees that at all times during the period of the employment relationship between Employee and the Company, Employee shall
refrain from using, disclosing or revealing to the Company any Third Party Confidential Information. 
 5. NON-SOLICITATION COVENANT: During
Employee’s employment and for the one (1) year period following the termination thereof, Employee will not: 
 (a) directly or
indirectly, on behalf of Employee or for any other Person (other than the Company), hire, entice, induce, encourage or solicit, or attempt to hire, entice, induce, encourage or solicit any employee to leave the Company’s employ; or 

(b) cause or attempt to cause any employee of the Company to become employed by any Person associated with a Competing Organization or engaged
in the Business of the Company; or 
 (c) solicit or accept business, directly or indirectly, related to product or services competitive
with those of the Company, from any of the Company’s customers with whom the Employee has contact within one (1) year prior to Employee’s termination. 

  
 5 

 6. NON-COMPETE COVENANT: Employee agrees that for a period of one (1) year after termination
of employment, Employee will not compete, directly or indirectly, with the Company in the Field of Cartilage Regeneration and Repair. Competition includes, but is not limited to, the design, development, production, promotion, offering for sale or
sale of product or services competitive with those of the Company in the Field of Cartilage Regeneration and Repair. 
 7. RETURN OF COMPANY PROPERTY
AND CONFIDENTIAL INFORMATION: All records, files photo/videographic materials, customer lists, supplier lists, software, keys, equipment, credit cards or other tangible material, and all other documents, including but not limited to
Confidential Information, relating to the Business of the Company (collectively “property”) that Employee receives, acquires, produces or has access to during employment, are the exclusive property of the Company. Upon termination of
Employee’s employment, Employee shall return to the Company all property and all Confidential Information of the Company and all copies thereof in Employee’s possession or control regardless of how such property or Confidential Information
is obtained or maintained. 
 8. REMEDIES FOR BREACH: Employee agrees that any breach of this Agreement by Employee will cause the Company to
suffer immediate and irreparable injury, for which there is no adequate remedy at law. In the event of a breach or threatened breach of any of the terms of the Agreement, the Company shall be entitled to seek and obtain enforcement of this Agreement
in a court of competent jurisdiction by means of a decree of specific performance, an injunction without posting a bond or the requirement of any other guarantee, and any other form of equitable relief. Employee consents to the entry of such an
order. This provision is in addition to and does not replace any other remedies the Company may have at law or in equity, including the right to receive monetary damages. Employee shall reimburse the Company for all reasonable attorneys’ fees
and costs incurred by the Company in enforcing this Agreement. 
 9. SURVIVAL; SEVERABILITY AND ENFORCEABILITY: This Agreement shall survive
the termination of Employee’s employment with the Company. It is the intention of the parties that this Agreement shall be enforceable to the fullest extent allowed by law. This Agreement is devisable and separable so that if any provision
shall be held to be invalid, unlawful or enforceable, such holding shall not impair the remaining provisions. If any provision is held to be too broad or unreasonable in duration, scope or character of restriction to be enforced, such provision
shall be amended or modified (including “blue pencilled”) to the extent necessary to legally enforce such provision to the fullest extent permitted by law. This Agreement, including the rights and obligations hereunder including all rights
of enforcement, may be transferred and/or assigned to the Company. 

  
 6 

 10. EMPLOYEE’S OPPORTUNITY OF INDEPENDENT REVIEW OF THIS AGREEMENT PRIOR TO EXECUTION:
Employee acknowledges that he or she has been provided the opportunity by the Company to have this Agreement reviewed by an attorney or counsel of Employee’s own choosing prior to signing this Agreement. 

11. APPLICABLE LAW: This Agreement shall be construed and governed for all purposes under the laws of the Commonwealth of Massachusetts
without regard to conflict of law principles. 
 12. ENTIRE AGREEMENT: This Agreement constitutes the entire understanding between the parties
and supersedes all prior understandings, oral or written discussions and representations ever made, and agreements executed by Employee relating to this subject matter. No amendment, waiver or revocation of this Agreement shall be effective unless
set forth in writing expressly stating the amendment, waiver or revocation and signed by Employee and an authorized officer of the Company. 

IN WITNESS WHEREOF, the parties have executed this Agreement on the day and year noted above. 

 

									
					
	For:	 	  
	 		  	For:	  	HISTOGENICS CORPORATION
				
	  
	 		  	By:	  	  

			
	  
	 		  	  

	 Date
	 		 		  	Title	  	

  
 7EX-10.4

 Exhibit 10.4 
  

			
	

	 	 Histogenics Corporation

830 Winter Street
 Waltham, MA
02451
 781-547-7900 (phone)

781-547-4452 (fax)

 September 23, 2013 
 Nancy
M. Lynch, M.D. 
 210 42nd Ave. 
 San Mateo, CA 94403 

 

	Re:	Offer of Position of Chief Medical Officer with Histogenics Corporation 

 Dear Nancy 

I am pleased to offer you the position of Chief Medical Officer with Histogenics Corporation (the “Company”) with a start date of
September 23, 2013. The purpose of this letter is to describe the general terms and conditions of your employment with the Company (the “Offer”). 

Duties and Responsibilities 
 Your duties
and responsibilities will include those normally associated with the position of Chief Medical Officer and such other duties and responsibilities as reasonably may be assigned to you from time to time by the President & Chief Executive
Officer of the Company. Your employment with the Company will be on a full-time basis and you will report to the Chief Executive Officer. You will be expected to devote full time and effort to the business of the Company. You will not be required to
live in any specific geographic location in order to perform your duties and responsibilities. 
 Salary Compensation 

Your annual salary will be $260,000 paid in semi-monthly installments in accordance with our normal payroll policies, less applicable legal
deductions, payable in accordance with the regular payroll practices of the Company. 
 Sign-On Bonus 

As soon as practicable following your commencement of employment, you will be paid a sign-on bonus of $25,000, less applicable deductions.
However, if you voluntarily terminate your employment prior to September 23, 2014, you will be required to repay a pro-rata portion of the sign-on bonus equal to the full bonus less 1/12 of the bonus for each full month of employment completed.

 Nancy M. Lynch, M.D. 

September 23, 2013 
  Page
 2
 
  

 Bonus Compensation 

You will be eligible for an annual bonus (“bonus”), at the discretion of the Board of Directors (the “Board”), based upon
the recommendation of the President & Chief Executive Officer. The Company expects that bonuses will typically be determined and paid within 90 days from the end of the Company’s fiscal year. Your bonus, if any, will be in an amount up
to 40% of your annual salary, which is commensurate with the Senior Vice President level of the Company. The bonus will be determined by the Board based on the Company’s performance and success at achieving its objectives and goals during the
course of the year as well as your performance and success at achieving the objectives and goals set for you individually. You must be employed by Histogenics on the date bonuses are paid to receive a bonus. 

Equity/Stock Options 
 After your
acceptance of this offer of employment, upon approval of the Board of Directors, you will be issued a grant of 300,000 stock options commensurate with the Company’s Vice President level of common stock of the Company (the “Options”).
The Options will vest over four years, with 25% vesting on a ‘cliff’ basis on your one-year anniversary of your commencement of your employment (“Start Date”) and the remainder will vest 2.08334% each month thereafter on the
anniversary of your Start Date. The Options will vest upon a liquidity event according to the terms of the Employee Stock Option agreement. 

Termination 
 In the event that your
employment is terminated by either you or the Company for any reason, the Company will pay to you all Base Salary and unused vacation earned through the date of termination of employment. You will also be reimbursed for any reasonable business
expenses that you incurred prior to the termination of employment, as long as you properly account for the expenses and submit appropriate documentation to the Company pursuant to Expenses Section below. 

Severance 
 (a) General. If you are
subject to an Involuntary Termination, then you will be entitled to the benefits described in this “Severance” section. However, this section will not apply unless you (i) have returned all Company property in your possession and
(ii) have executed a general release of claims that you may have against the Company or persons affiliated with the Company. The release must be in a form prescribed by the Company. You must execute and return the release on or before the date
specified by the Company in the prescribed form (the “Release Deadline”). The Release Deadline will in no event be later than 60 days after termination of your employment. If you fail to return the release on or before the Release
Deadline, or if you revoke the release, then you will not be entitled to the benefits described in this Section. 

 Nancy M. Lynch, M.D. 

September 23, 2013 
  Page
 3
 
  

 (b) Salary Continuation. In the event you are subject to an Involuntary Termination,
the Company will continue to pay your base salary for a period of 12 months after your Separation (the “Continuation Period”). Your base salary will be paid at the rate in effect at the time of your Separation and in accordance with the
Company’s standard payroll procedures. The salary continuation payments will commence within 30 days after the Release Deadline and, once they commence, will be retroactive to the date of your Separation. 

(c) Health Insurance. If you are subject to an Involuntary Termination, and if you elect to continue health insurance coverage under
the Consolidated Omnibus Budget Reconciliation Act (“COBRA”) for you and, if applicable, your dependents following the Separation, then the Company shall pay the employer portion of the monthly premium under COBRA for you and, if
applicable, such dependents until the earliest of (i) the close of the Continuation Period, (ii) the expiration of your continuation coverage under COBRA or (iii) the date when you receive substantially equivalent health insurance
coverage in connection with new employment or self-employment. 
 (d) Section 409A. For purposes of Section 409A of the
Internal Revenue Code of 1986, as amended (the “Code”), each salary continuation payment under this section is hereby designated as a separate payment. If the Company determines that you are a “specified employee” under
Section 409A(a)(2)(B)(i) of the Code at the time of your separation from service (as defined in the regulations under Section 409A), then (i) the salary continuation payments under this Section, to the extent that they are subject to
Section 409A of the Code, will commence during the seventh month after your separation from service and (ii) the installments that otherwise would have been paid during the first six months after your separation from service will be paid
in a lump sum when the salary continuation payments commence. 
 (e) Certain Definitions. 

“Cause” shall mean a good faith determination by the Board of any of the following: 

 

	 	(i)	An unauthorized use or disclosure by you of the Company’s confidential information or trade secrets, which use or disclosure causes material harm to the Company; 

 

	 	(ii)	A material breach by you of any agreement between you and the Company; 

  

	 	(iii)	A material failure by you to comply with the Company’s written policies or rules after receiving written notification of such failure from the Board and a reasonable opportunity to cure such failure;

 Nancy M. Lynch, M.D. 

September 23, 2013 
  Page
 4
 
  

	 	(iv)	The sale, possession or use of illegal drugs by you or your habitual intoxication on the premises of the Company or a customer or business partner of the Company or while conducting Company business; 

 

	 	(v)	Your conviction of, or plea of “guilty” or “no contest” to, a felony under the laws of the United States or any State thereof; 

 

	 	(vi)	Your gross negligence or willful misconduct in the course of performing service to the Company; 

  

	 	(vii)	A continuing failure by you to perform reasonably assigned duties after receiving written notification of such failure from the Board and a reasonable opportunity to cure such failure; or 

 

	 	(viii)	A failure by you to cooperate in good faith with a governmental or internal investigation of the Company or its directors, officers or employees, if the Company has requested your cooperation. 

“Involuntary Termination” shall mean either (a) your Termination Without Cause or (b) your Resignation for Good
Reason. 
 “Resignation for Good Reason” means a Separation as a result of your resignation after one of the following
conditions has come into existence without your consent: 
  

	 	(i)	A material reduction in your base salary; 

  

	 	(ii)	A material breach by the Company of its obligations under this letter agreement; or 

  

	 	(iii)	A change in your title or position with the Company that materially reduces your level of authority or responsibility. 

A Resignation for Good Reason shall not be deemed to have occurred unless you give the Company written notice of the condition within 15 days after the
condition comes into existence and the Company fails to remedy the condition within 15 days after receiving your written notice. 

“Separation” shall mean a “separation from service,” as defined in the regulations under Section 409A of the
Code. 

 Nancy M. Lynch, M.D. 

September 23, 2013 
  Page
 5
 
  

 “Termination Without Cause” means a Separation as a result of a termination
of the Employee’s employment by the Company without Cause, provided the Employee is willing and able to continue performing services within the meaning of Treasury Regulation 1.409A-1(n)(1). 

Vacation 
 You will be eligible to take up
to 3 weeks of paid vacation time per year, calculated from your Start Date and consistent with the Company’s vacation policy. Such vacation time is accrued on a monthly basis. 

Expenses 
 The Company will reimburse you
for all actual, necessary and reasonable expenses you incur in the course of the Company’s business, subject to the Company’s expense policy. 

Payments and Benefits 
 You will be
entitled to participate in any employee medical, dental, and life insurance plans and other benefits generally available to the Company’s employees. The Company, of course, may amend, terminate, or enhance the benefits provided to you and our
other employees from time to time as it deems appropriate. 
 Directors and Officers Insurance 

The Company, at its own expense, shall provide you with the same Directors and Officers insurance it provides to its executive employees from
time to time, with coverage limits that are customary for directors and officers of companies in the Company’s industry and at the Company’s stage of development. 

Relocation Expenses 
 At some point in the
future while you remain fully employed by the Company, should you choose to relocate to the locale of the corporate office for the primary purpose of facilitating your performance of your duties and responsibilities, the Company shall provide
reasonable relocation support and expense reimbursement to be determined at that time. 
 Maintenance of Licensure and Board Certification 

The Company encourages you to maintain your license to practice medicine and your board certification in orthopaedic surgery to the extent that
you are able and willing to do so. To that end, the Company will allow a reasonable amount of your time to be spent meeting the requirements for continuing medical education and recertification as necessary and will reimburse reasonable expenses
associated with such endeavors in accordance with the Company’s expense policy. 

 Nancy M. Lynch, M.D. 

September 23, 2013 
  Page
 6
 
  

 Internal Policies 

During your employment with the Company, you will be required to follow all of the Company’s internal policies and to conduct your
business activities at all times in accordance with the highest legal, ethical and professional standards. 
 Employment At Will 

The terms of this Offer do not and are not intended to create either an express and/or implied contract of employment with the Company. Your
employment with the Company is for no specified period and constitutes “at-will” employment in that it can be terminated with or without cause at any time, and with or without notice, at the option of either the Company or yourself, except
as otherwise provided by law. The Company is not bound to follow any policy, procedure, or process in connection with employee discipline, employment termination, or otherwise. 

No Conflicting Obligation/Conflicts of Interest 

You hereby represent and warrant to the Company that you are not presently under and will not become subject to any obligation to any person or
entity which is inconsistent or in conflict with your employment with the Company or which would prevent, limit or impair in any way your performance of your duties to the Company as described in this Offer. Specifically you represent and warrant
that you have not brought with you any confidential or proprietary information of any former employer, and you are not subject to any agreement or obligation with a former employer that would prohibit your employment by the Company. It is recognized
and allowed by the Company that you have existing consulting contracts and/or professional obligations that you will honor and fulfill. Should at any point during your employment with the Company the contracts and/or obligations present a conflict
with regard to your nondisclosure agreement with the Company, you will be required to recuse yourself from further discussions under those contracts or terminate those contracts or obligations. You may not enter into any additional consulting
contracts and/or professional obligations during the course of your employment with the Company without first obtaining approval from the Chief Executive Officer. 

Proprietary Information, Inventions and Non-Solicitation Agreement 

As a condition to your employment by the Company and in consideration of the issuance of stock options to you, you are required to enter into
the Proprietary Information, Inventions and Non-Solicitation Agreement (“the Agreement”) (attached as Exhibit A). Among other things, the Agreement provides that the Company owns your work product and all developments made by
you related to the Company’s business; that you will hold all non-public information regarding the Company confidential; and that for a one year period following your employment you will not solicit, hire, divert or take away any employee,
contractor, customer or supplier of the Company. 

 Nancy M. Lynch, M.D. 

September 23, 2013 
  Page
 7
 
  

 Conditions of Employment 

This offer is contingent upon your providing satisfactory documentation to the Company concerning your employment eligibility as required by
Congress under the Immigration Reform and Control Act of 1986. This documentation must be received and accepted by the Company within three (3) business days of your date of hire. 

Governing Law 
 This Offer will be
governed, construed and enforced in accordance with the laws of Massachusetts, without regard to principles of choice or conflicts of law. 
 Arbitration

 You agree to arbitrate before a single neutral arbitrator, in accordance with the rules of the state of Massachusetts and the
Institute of Business Arbitration, any disputes or claims that concern your employment, the termination of that employment, your recruitment, or any term or condition of your employment or this Offer. The Company will pay the cost of the arbitration
filing and hearing fees and the cost of the arbitrator, and any other expense or cost that is unique to arbitration or that you would not be required to bear if you were free to bring the dispute or claim in court. Each party will bear its own
attorney fees. Nothing in this Offer will be interpreted as restricting or prohibiting you from filing a charge or complaint with an administrative agency charged with investigating and/or prosecuting such charges or complaints under any applicable
law or regulation. The arbitration will take place in the United States. The arbitrator will issue a written award that sets forth the essential findings and conclusions on which the award is based. Judgment on the award rendered by the arbitrator
may be entered in any court having jurisdiction thereof. The award will be subject to correction, confirmation, or vacation, as provided by any applicable Massachusetts statutory or case law setting forth the standard of judicial review of
arbitration awards. Notwithstanding the foregoing, the parties may apply to any court of competent jurisdiction for preliminary or interim equitable relief, or to compel arbitration in accordance with this Offer, without breach of this arbitration
provision. You understand and agree that the arbitration of disputes or claims that relate to this Offer will be instead of a hearing or trial before a court. You understand that you are expressly waiving any and all rights to a hearing or trial
before a court, regarding any disputes and claims which they now have or which they may in the future have that relate to this Offer. The only disputes or claims to which the obligations to arbitrate contained in this Section will not apply are to
any dispute or claim for workers’ compensation benefits or unemployment insurance benefits. 

 Nancy M. Lynch, M.D. 

September 23, 2013 
  Page
 8
 
  

 Entire Understanding 

This letter contains our entire understanding regarding the terms and conditions of your employment and supersedes any prior statements
regarding your employment made to you at any time by any representative of the Company. No representative of the Company, except the Chairman of the Board as authorized by the Board, has the authority to enter into any agreement contrary to the
foregoing. If the foregoing Offer is acceptable to you, please acknowledge your acceptance by signing below and returning one copy of this letter. 
  

	
	 Very truly yours,
 Kevin McArdle

	
	 /s/ Kevin McArdle

	Chief Financial Officer

  

			
	ACCEPTED:
	
	 /s/ Nancy M. Lynch

	Nancy M. Lynch, M.D.
		
	Date:	 	 October 10, 2013

 

 
 Exhibit A 

CONFIDENTIAL INFORMATION AND 

INTELLECTUAL PROPERTY ASSIGNMENT AGREEMENT 

This Confidential Information and Intellectual Property Assignment Agreement (hereafter referred to as “Agreement”) dated as of
                                 by and between HISTOGENICS CORPORATION
(hereinafter referred to as the “Company”), a Delaware Corporation having a place of business at 830 Winter Street, Waltham, MA 02451, and
                             (hereinafter referred to as the “Employee”), a United States
citizen/legal resident having a residence at
                                         
   . 
 The Company has requested that the Employee execute this Agreement, and the Employee has agreed to execute this
Agreement as part of the terms of Employee being hired, or continued employment of Employee, by the Company; 
 The Company possesses
certain Confidential Information, as defined below in Section 1.5 of this Agreement, that is confidential and proprietary to the Company; 

The Employee may receive or come into possession of Confidential Information from time to time to carry out the Employee’s duties under
the direction of the Company; 
 In furtherance of the foregoing, and in consideration of employment of Employee by the Company, the Company
and the Employee agree as follows: 
 1. DEFINITIONS 

For the purposes of this Agreement, the following terms shall have the following meanings: 

1.1 “Company” means HISTOGENICS CORPORATION, its present or future subsidiaries, affiliates and any entity owned or controlled by or
under common control, including any businesses that may be acquired or established after the execution of this Agreement and employment with the Company, and any successor-in-interest thereto or assignee thereof. 

1.2 “Business of the Company” includes any services or products (including both generic and specific products) used, made, sold,
offered for sale, developed, commenced or planned to be sold by the Company at any time during the Employee’s employment or used, made, sold, offered for sale, developed, commenced or planned to be sold by the Company using Confidential
Information, Intellectual Property or Work Product after termination of the Employee’s employment either by the Employee or the Company. 

 1.3 “Person” and “Persons” mean all individuals, partnerships,
corporations, limited liability companies, firms, businesses, organizations and other entities. 
 1.4 “Field of Research” means the
development of procedures and products related to ex corpus, in situ, in vitro or in vivo growth of cells or tissue for use in a mammalian body such as the human body, including, by way of example and without limitation,
methods of cartilage, ligament and tendon culture, autologous cultured cell technology, the biology of chondrocyte implantation, the applicability of such technology in the treatment of new indications and disease states, the development and
identification of new indications and usages for the Company’s products and procedures, and any and all other procedures and products associated or used with ex corpus, in situ, in vitro or in vivo growth of cells or
tissue for use in a mammalian body. 
 1.5 “Confidential Information” means: 

(a) All information, ideas, trade secrets and all other confidential and proprietary information of the Company, including without limitation
any and all information relating in any manner whatsoever to the Field of Research or the Business of the Company, financial information of the Company, the terms and formats of the Company’s contracts and agreements, information pertaining to
the Company’s methods of operation, processes, strategies and techniques, customer lists, customer information, and information relating to employees of the Company, including but not limited to employees’ identities, home and business
telephone and pager numbers, and addresses; 
 (b) Provided that the information: (i) becomes known to Employee as a consequence of
Employee’s employment with the Company, or was wrongfully obtained by Employee, regardless of whether the information became known to Employee during or after working hours, or whether the information came into the Company’s possession
through the efforts of Employee or others; and (ii) is not readily available to the public; and 
 (c) The definition of
“Confidential Information” is intended to have the broadest meaning as permitted by law and extends beyond the definition of “trade secrets” as set forth in the Uniform Trade Secrets Act. 

1.6 “Employee” means the individual signing this Agreement who is either currently employed by the Company or becoming an employee of
the Company concurrently with the execution of this Agreement. 
 1.7 “Intellectual Property” means any and all ideas, Inventions,
know how, improvements, discoveries, techniques, processes, original works of authorship, trade secrets and other subject matter developed or made by the Employee (solely or jointly with others) that may be protected, at least in part, by one or
more of a patent, trademark, copyright, trade secret, trade dress or other legal protection in the United States or in any foreign country. 

  
 2 

 1.8 “Inventions” means any and all discoveries, concepts, ideas, whether patentable or
not patentable, including but not limited to processes, methods, formulae, software, techniques, algorithms, cells, tissues, organs, cell cultures, cell parts, organisms, natural or non-naturally occurring genetic materials such as DNA constructs,
products, such as proteins, antibodies and the like, that are derived from or produced using natural or non-naturally occurring genetic materials, as well as improvements thereof or know-how related thereto, concerning any present or prospective
activities of the Company with which the Employee becomes acquainted or gains knowledge of as a result of the Employee’s employment by the Company. 

1.9 “Competing Organization” means any Person engaged in or about to become engaged in research on, development of, production,
marketing, selling of, or offering for sale a Competing Product. 
 1.10 “Competing Product” means any product, process, good
or service of any Person other than the Company, in existence or under development, which competes, directly or indirectly, with a product, process, good or service on or with which the Employee has worked for the Company or about which the Employee
has Confidential Information. 
 1.11 “Work Product” means designs, drawings, software, photographs, plans, records,
improvements, ideas and other subject matter relating thereto that is not considered by the Company to be Intellectual Property. 
 2. EMPLOYEE’S
REPRESENTATIONS AND AGREEMENTS 
 2.1 Confidential Information and Goodwill: Solely as a result of employment with the Company,
Employee will be given access to, become familiar with, and will acquire knowledge of the Company, its employees, operations, methods, sources of supply, financial information, the Field of Research, the Business of the Company and other
Confidential Information of the Company. The Confidential Information has been and will continue to be developed through the Company’s investment of substantial time, effort and money. Employee recognizes that disclosure or use of Confidential
Information for any purpose to any third party or Competing Organization would be greatly prejudicial and detrimental to the Company and would cause the Company to suffer immediate and irreparable injury. Employee further recognizes that Employee is
in a position to unfairly convert or otherwise use the Company’s business and goodwill for use by Employee and a Competing Organization to produce, make, have made, sell, offer for sale, or import a Competing Product, and that such conversion
or use would be greatly prejudicial to the Company, and would cause the Company to suffer immediate and irreparable injury. 
 2.2 Ownership of
Employee Work Product: The Company and Employee agree: 
 (a) that the Company shall own in its entirety and have the entire right
to use, made, have made, sell, offer for sale or import without the payment to the Employee of any royalty or amount or the provision of any consideration to Employee, other than 

  
 3 

 
continued employment of the Employee by the Company, all Work Product and all results of the performance by Employee of Employee’s duties and responsibilities as an employee of the Company.
Employee specifically agrees that any Work Product made or conceived by Employee during the period of employment of Employee by the Company shall be delivered to and become the property of the Company; and 

(b) that Employee is obligated to assign and will assign all right, title and interest in and to the Work Product to the Company, without the
payment of any royalty or amount or the provision of any consideration to the Employee other than continued employment by the Company. 
 2.3 Employee
Intellectual Property: Employee agrees that with respect to Intellectual Property made or conceived by the Employee, whether or not during the hour of Employee’s engagement or with the use of assistance of any Company facility,
material, or personnel, either solely or jointly with others during Employee’s employment with the Company or within one year after termination of such employment, without payment, royalty or any other consideration to the Employee other than
Employee’s wages or salary, therefore: 
 (a) The Employee shall inform the Company promptly and fully of all such Intellectual
Property by written reports, setting forth in detail the procedures, steps, materials and the like employed and the results achieved. The Employee shall submit an invention disclosure report promptly after completion of any studies or research
projects undertaken on the Company’s behalf, or funded at least in part by the Company, whether or not in the Employee’s opinion or view a given project has resulted in any Invention; 

(b) The Employee hereby transfers, assigns and agrees to assign to the Company, without any royalty, payment or consideration other than
Employee’s wages or salary which shall be considered full and adequate consideration, his or her entire right, title and interest in and to all Intellectual Property and to applications for United States and foreign patent applications and
patents granted thereon and to any trademarks, trade dress or copyrightable material related thereto; 
 (c) The Employee agrees for himself
or herself and his or her heirs, representatives, successors in interest, and assigns, upon request of the Company, at all times to perform such acts, such as providing testimony in support of the Employee’s inventorship and to execute and
deliver promptly to the Company such papers, instruments and documents, without expense to him or her, as from time to time may be necessary or useful in the Company’s opinion to apply for, secure, maintain, enforce, reissue, extend or defend
the Company’s worldwide rights in any Intellectual Property so as to secure to the Company the full benefits of the Intellectual Property and otherwise to carry into full force and effect the text and the assignment described above; 

(d) The Employee warrants and represents to the Company that he or she is not subject to any agreement, government contract, government grant
or university policy inconsistent with this Agreement. The Employee agrees not to conduct any research or other work subject to this Agreement other than at the Company’s facilities and further agrees not to use any such research facilities,
materials or personnel of any university or other Person not rented, leased or otherwise hired by the Company in connection with such work; and 

  
 4 

 (e) The Employee acknowledges that any copyrightable work created by Employee during the period
of Employee’s employment relationship with the Company shall be considered a work made for hire, and rights therein shall be the exclusive property of the Company as author and owner of the copyright in and to such work. 

2.4 Shop Rights: Notwithstanding any provision herein that may create greater rights, Employee acknowledges that the Company shall have the
royalty-free right to use in its business, and to make, have made, use, sell, offer for sale or import products, processes and services derived from or related to any Intellectual Property or Work Product that are made or conceived by the Employee
during his or her employment by the Company or with the use or assistance of the Company’s facilities or funded, at least in part, with Company funds. 

3. NON-DISCLOSURE OF CONFIDENTIAL INFORMATION: At no time, either during or after the termination of employment, shall Employee directly or
indirectly obtain, disclose, reveal or use for Employee or any Person or Competing Organization, or aid others in obtaining, disclosing, revealing or using any Confidential Information of the Company, other than as may be required in the performance
of duties for and as authorized by the Company. All Confidential Information is and shall remain the sole property of the Company. 
 4. NONDISCLOSURE
OF OTHER INFORMATION: The Company and Employee acknowledge and agree that: 
 (a) Employee may be aware of certain other
confidential information of one or more third parties (the “Third Party Confidential Information”). 
 (b) The Company and
Employee further acknowledge and agree that the Company has not requested that Employee disclose to the Company any Third Party Confidential Information and, in fact, the Company requires that Employee refrain at all times during the period of the
employment relationship between the Company and Employee from using, disclosing or revealing to the Company any Third Party Confidential Information. 

(c) Employee agrees that at all times during the period of the employment relationship between Employee and the Company, Employee shall
refrain from using, disclosing or revealing to the Company any Third Party Confidential Information. 
 5. NON-SOLICITATION COVENANT: During
Employee’s employment and for the one (1) year period following the termination thereof, Employee will not: 
 (a) directly or
indirectly, on behalf of Employee or for any other Person (other than the Company), hire, entice, induce, encourage or solicit, or attempt to hire, entice, induce, encourage or solicit any employee to leave the Company’s employ; or 

(b) cause or attempt to cause any employee of the Company to become employed by any Person associated with a Competing Organization or engaged
in the Business of the Company; or 
 (c) solicit or accept business, directly or indirectly, related to product or services competitive
with those of the Company, from any of the Company’s customers with whom the Employee has contact within one (1) year prior to Employee’s termination. 

  
 5 

 6. NON-COMPETE COVENANT: Employee agrees that for a period of one (1) year after termination
of employment, Employee will not compete, directly or indirectly, with the Company in the Field of Cartilage Regeneration and Repair. Competition includes, but is not limited to, the design, development, production, promotion, offering for sale or
sale of product or services competitive with those of the Company in the Field of Cartilage Regeneration and Repair. 
 7. RETURN OF COMPANY PROPERTY
AND CONFIDENTIAL INFORMATION: All records, files photo/videographic materials, customer lists, supplier lists, software, keys, equipment, credit cards or other tangible material, and all other documents, including but not limited to
Confidential Information, relating to the Business of the Company (collectively “property”) that Employee receives, acquires, produces or has access to during employment, are the exclusive property of the Company. Upon termination of
Employee’s employment, Employee shall return to the Company all property and all Confidential Information of the Company and all copies thereof in Employee’s possession or control regardless of how such property or Confidential Information
is obtained or maintained. 
 8. REMEDIES FOR BREACH: Employee agrees that any breach of this Agreement by Employee will cause the Company to
suffer immediate and irreparable injury, for which there is no adequate remedy at law. In the event of a breach or threatened breach of any of the terms of the Agreement, the Company shall be entitled to seek and obtain enforcement of this Agreement
in a court of competent jurisdiction by means of a decree of specific performance, an injunction without posting a bond or the requirement of any other guarantee, and any other form of equitable relief. Employee consents to the entry of such an
order. This provision is in addition to and does not replace any other remedies the Company may have at law or in equity, including the right to receive monetary damages. Employee shall reimburse the Company for all reasonable attorneys’ fees
and costs incurred by the Company in enforcing this Agreement. 
 9. SURVIVAL; SEVERABILITY AND ENFORCEABILITY: This Agreement shall survive
the termination of Employee’s employment with the Company. It is the intention of the parties that this Agreement shall be enforceable to the fullest extent allowed by law. This Agreement is devisable and separable so that if any provision
shall be held to be invalid, unlawful or enforceable, such holding shall not impair the remaining provisions. If any provision is held to be too broad or unreasonable in duration, scope or character of restriction to be enforced, such provision
shall be amended or modified (including “blue pencilled”) to the extent necessary to legally enforce such provision to the fullest extent permitted by law. This Agreement, including the rights and obligations hereunder including all rights
of enforcement, may be transferred and/or assigned to the Company. 

  
 6 

 10. EMPLOYEE’S OPPORTUNITY OF INDEPENDENT REVIEW OF THIS AGREEMENT PRIOR TO EXECUTION:
Employee acknowledges that he or she has been provided the opportunity by the Company to have this Agreement reviewed by an attorney or counsel of Employee’s own choosing prior to signing this Agreement. 

11. APPLICABLE LAW: This Agreement shall be construed and governed for all purposes under the laws of the Commonwealth of Massachusetts
without regard to conflict of law principles. 
 12. ENTIRE AGREEMENT: This Agreement constitutes the entire understanding between the parties
and supersedes all prior understandings, oral or written discussions and representations ever made, and agreements executed by Employee relating to this subject matter. No amendment, waiver or revocation of this Agreement shall be effective unless
set forth in writing expressly stating the amendment, waiver or revocation and signed by Employee and an authorized officer of the Company. 

IN WITNESS WHEREOF, the parties have executed this Agreement on the day and year noted above. 

 

									
					
	For:	 	  
	 		  	For:	  	HISTOGENICS CORPORATION
				
	  
	 		  	By:	  	  

			
	  
	 		  	  

	 Date
	 		 		  	Title	  	

  
 7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}]]